Examples of using Do not use in dogs in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
Do not use in dogs weighing less than 3 kg.
Do not use in dogs younger than 7 months old!
Do not use in dogs weighing less than 4 kg.
Do not use in dogs less than 10 weeks of age.
Do not use in dogs with generalised demodecosis.
Do not use in dogs less than 6 weeks of age.
Do not use in dogs under 14 weeks of age.
Do not use in dogs less than 4 months of age.
Do not use in dogs weighing less than 4 kg.
Do not use in dogs with impaired liver function.
Do not use in dogs with extensive lesions.
Do not use in dogs or cats under 14 weeks of age.
Do not use in dogs with known quinolone hypersensitivity.
Do not use in dogs with generalised demodicosis.
Do not use in dogs with known quinolone hypersensitivity.
Do not use in dogs with gastrointestinal bleeding.
Do not use in dogs with evidence of stomach bleeding.
Do not use in dogs with known quinolone hypersensitivity.
Do not use in dogs and cats with known quinolone hypersensitivity.
Do not use in dogs with severe cardiovascular disorders.
Do not use in dogs obviously sedated from previous dosing.
Do not use in dogs during pregnancy and lactation(see section 4.7). Cats.
Do not use in dogs less than 12 months of age or less than 3 kg bodyweight.
Do not use in dogs suffering from hypoadrenocorticism, hyperkalaemia or hyponatraemia.
Do not use in dogs suffering from gastrointestinal disorders or haemorrhagic disorders.
Do not use in dogs during the period of growth as articular cartilage may be affected.
Do not use in dogs suffering from liver impairment, defined as AST or ALT> 3 x Upper Limit of Normal(ULN).
Do not use in dogs during the period of growth as developing articular cartilage may be affected.
Do not use in dogs suffering from renal function impairment, defined as Urinary Protein Creatinine(UPC) ratio> 2 or albumin< 1 x Lower Limit of Normal(LLN).
Do not use in dogs with evidence of immune suppression, such as hyperadrenocorticism, or with evidence of progressive malignant neoplasia as the active substance has not been evaluated in these cases.